Outcomes and economics of ESRF

Kidney Diseases in the Developing World and Ethnic Minorities

Volumn , Issue , 2005, Pages 15-37

  Lacson, Eduardo ^a   Kuhlmann, Martin K ^b   Shah, Kunal ^c   Yoshino, Maki ^c   Levin, Nathan W ^b  

^a FRESENIUS MEDICAL CARE NORTH AMERICA   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c RENAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33748424776     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (70)

1. Moeller S, Gioberge S, Brown G. ESRD patients in 2001: global overview of patients, treatment modalities and development trends. Nephrol Dial Transplant 2002; 17:2071-2076.
2. Fresenius Medical Care. ESRD Patients in 2003-a Global Perspective. Fresenius Medical Care Internal Survey, Bad Homburg, Germany, 2004:1-10.
3. Kher V. End-stage renal disease in developing countries. Kidney Int 2002; 62:350-362.
4. Cha V, Chugh KS. Dialysis in developing countries: priorities and obstacles. Nephrology 1996; 2:65-72.
5. Jha V. End-stage renal care in developing countries: the India experience. Ren Fail 2004; 26:201-208.
6. Keshaviah P. Resource limitations and strategies for the treatment of uremia: a dialysis unit in the Himalayan foothills. Blood Purif 2001; 19:44-52.
7. Li L. End stage renal disease in China. Kidney Int 1996; 49:287-301.
8. Lin S. Nephrology in China: a great mission and momentous challenge. Kidney Int 2003; 63(suppl 83):S108-S110.
9. Berthoux F, Jones E, Gellert R, Mendel S, Saker L, Briggs D. Epidemiological data of treated end-stage renal failure in the European Union (EU) during the year 1995: report of the European Renal Association Registry and the National Registries. Nephrol Dial Transplant 1999; 14:2332-2342.
10. Rutkowski B, Ciocalteu A, Djukanovic L, Kiss I, Kovac A, Krivoshiev S, Kveder R, Polenakovic M, Puretic Z, Stanaityte M, Tareyeva I, Teplan V, Zavitz J. Evolution of renal replacement therapy in Central and Eastern Europe 7 years after political and economical liberation. Central and Eastern Europe Advisory Board in Chronic Renal Failure. Nephrol Dial Transplant 1998; 13:860-864.
11. Lameire N, Joffe P, Wiedemann M. Healthcare systems-an international review:an overview. Nephrol Dial Transplant 1999; 14(suppl 6):3-9.
12. Winkelmayer WC, Weinstein MC, Mittleman MA, Glynn RJ, Pliskin JS. Health economic evaluations: the special case of end-stage renal disease treatment. Med Decis Making 2002; 22:417-430.
13. Kaminota M. Cost-effectiveness analysis of dialysis and kidney transplants in Japan. Keio J Med 2001; 50:100-108.
14. Erek E, Sever MS, Akoglu E, Sariyar M, Bozfakioglu S, Apaydin S, Ataman R, Sarsmaz N, Altiparmak MR, Seyahi N, Serdengecti K. Cost of renal replacement therapy in Turkey. Nephrology (Carlton) 2004; 9:33-38.
15. Kalo Z, Jaray J, Nagy J. Economic evaluation of kidney transplantation versus hemodialysis in patients with end-stage renal disease in Hungary. Prog Transplant 2001; 11:188-193.
16. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ, Port FK. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341:1725-1730.
17. Nevins TE, Matas AJ. Medication noncompliance: another iceberg’s tip. Transplantation 2004; 77:776-778.
18. Gulati S, Kumar A, Sharma RK, Gupta A, Bhandari M, Kumar A, Srivastava A. Outcome of pediatric renal transplants in a developing country. Pediatr Nephrol 2004; 19:96-100.
19. Rizvi SA. Present state of dialysis and transplantation in Pakistan. Am J Kidney Dis 1998; 31:xlv-xlviii.
20. Goyal M, Mehta RL, Schneiderman LJ, Sehgal AR. Economic and health consequences of selling a kidney in India. JAMA 2002; 288:1589-1593.
21. Anonymous. Commercially motivated renal transplantation: results in 540 patients transplanted in India. The Living Non-Related Renal Transplant Study Group. Clin Transplant 1997; 11:536-544.
22. Sever MS, Kazancioglu R, Yildiz A, Turkmen A, Ecder T, Kayacan SM, Celik V, Sahin S, Aydin AE, Eldegez U, Ark E. Outcome of living unrelated (commercial) renal transplantation. Kidney Int 2001; 60:1477-1483.
23. India Legislature. An Act (No 42 of 1994) to provide for the regulation of removal, storage and transplantation of human organs for therapeutic purposes and for the prevention of commercial dealings in human organs and for matters connected therewith or incidental thereto. Date of Assent by the President: 8 July 1994 (The Transplantation of Human Organs Act, 1994). Int Dig Health Legis 1995; 46:34-38.
24. Steer DL, Nigam SK. Developmental approaches to kidney tissue engineering. Am J Physiol Renal Physiol 2004; 86:F1-F7.
25. Hammerman MR. Organogenesis of kidneys following transplantation of renal progenitor cells. Transplant Immunol 2004; 12:229-239.
26. Lavillette D, Kabat D. Porcine endogenous retroviruses infect cells lacking cognate receptors by an alternative pathway: implications for retrovirus evolution and xenotransplantation. J Virol 2004; 78:8868-8877.
27. Fishman JA, Patience C. Xenotransplantation: infectious risk revisited. Am J Transplant 2004; 4:1383-1390.
28. Yang G. Application of xenogeneic stem cells for induction of transplantation tolerance.: present state and future directions. Springer Semin Immunopathol Sep 11 [Epub ahead of print], 2004.
29. Brown G. Dialysis funding and cost in Europe. Presentation at the World Congress of Nephrology, Berlin, 2003.
30. De Vecchi AF, Dratwa M, Wiedemann ME. Healthcare systems and end-stage renal disease (ESRD) therapies-an international review: costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant 1999; 14(suppl 6):31-41.
31. Rao M, Juneja R, Shirly RB, Jacob CK. Haemodialysis for end-stage renal disease in Southern India-a perspective from a tertiary referral care centre. Nephrol Dial Transplant 1998; 13:2494-2500.
32. Jacob C. Dialysis cost and funding in emerging nations. Presentation at the World Congress of Nephrology, Berlin, 2003.
33. Chartier K. Analysis: ten largest renal providers in 2004. Nephrol News Issues 2004; 18:41.
34. Cueto-Manzano AM. Peritoneal dialysis in Mexico. Kidney Int 2003; 63(suppl 83):S90-S92.
35. Sakhuja V, Sud K. End-stage renal disease in India and Pakistan: burden of disease and management issues. Kidney Int 2003; 63(suppl 83):S115-S118.
36. Zatz R, Romao JE Jr, Noronha IL. Nephrology in Latin America, with special emphasis on Brazil. Kidney Int 2003; 63(suppl 83):S131-S134.
37. Riella M. Dialysis funding and cost in Latin America. Presentation at the World Congress of Nephrology, Berlin, 2003.
38. Horl WH, de Alvaro F, Williams PF. Healthcare systems and end-stage renal disease (ESRD) therapies-an international review: access to ESRD treatments. Nephrol Dial Transplant 1999; 14(suppl 6):10-15.
39. U.S. Renal Data System. USRDS 2003 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health:National Institute of Diabetes and Digestive and Kidney Diseases 2003.
40. Ramirez SP, Durai TT, Hsu SI. Paradigms of public-private partnerships in end-stage renal disease care: the National Kidney Foundation Singapore. Kidney Int 2003; 63(suppl 83):S101-S107.
41. Bamgboye EL. Hemodialysis: management problems in developing countries, with Nigeria as a surrogate. Kidney Int 2003; 63(suppl 83):S93-S95.
42. Han H, Bleyer AJ, Houser RF, Jacques PF, Dwyer JT. Dialysis and nutrition practices in Korean hemodialysis centers. J Ren Nutr 2002; 12:42-48.
43. Sitprija V. Nephrology in South East Asia: fact and concept. Kidney Int 2003; 63(suppl 83):S128-S130.
44. Naiker S. End-stage renal disease in sub-Saharan and South Africa. Kidney Int 2003; 63(suppl 83):S119-S122.
45. Health Department of Western Australia. Review of End Stage renal Failure Services. Report of the Working Party. Perth, Australia: Health Department of Western Australia, 1994.
46. Trivedi HS, Pang MM, Campbell A, Saab P. Slowing the progression of chronic renal failure: economic benefits and patients’ perspectives. Am J Kidney Dis 2002; 39:721-729.
47. Held PJ, Brunner F, Odaka M, Garcia JR, Port FK, Gaylin DS. Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987. Am J Kidney Dis 1990; 15:451-457.
48. Young EW, Goodkin DA, Mapes DL, Port FK, Keen ML, Chen K, Maroni BL, Wolfe RA, Held PJ. The Dialysis Outcomes and Practice Patterns Study (DOPPS): an international hemodialysis study. Kidney Int 2000; 57(suppl 74):S74-S81.
49. Stack AG, Messana JM. Renal replacement therapy in the elderly: medical, ethical, and psychosocial considerations. Adv Ren Replace Ther 2000; 7:52-62.
50. Harvey JN. Trends in the prevalence of diabetic nephropathy in type 1 and type 2 diabetes. Curr Opin Nephrol Hypertens 2003; 12:317-322.
51. Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, Saito A, Rayner HC, Kurokawa K, Port FK, Held PJ, Young EW. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 2003; 14:3270-3277.
52. Fukuhara S, Lopes AA, Bragg-Gresham JL, Kurokawa K, Mapes DL, Akizawa T, Bommer J, Canaud BJ, Port FK, Held PJ, Worldwide Dialysis Outcomes, Practice Patterns Study. Health-related quality of life among dialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2003; 64:1903-1910.
53. Mapes DL, Lopes AA, Satayathum S, McCullough KP, Goodkin DA, Locatelli F, Fukuhara S, Young EW, Kurokawa K, Saito A, Bommer J, Wolfe RA, Held PJ, Port FK. Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 2003; 64:339-349.
54. Saran R, Bragg-Gresham JL, Rayner HC, Goodkin DA, Keen ML, Van Dijk PC, Kurokawa K, Piera L, Saito A, Fukuhara S, Young EW, Held PJ, Port FK. Nonadherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS. Kidney Int 2003; 64:254-262.
55. Port FK, Wolfe RA, Hulbert-Shearon TE, McCullough KP, Ashby VB, Held PJ. High dialysis dose is associated with lower mortality among women but not among men. Am J Kidney Dis 2004; 43:1014-1023.
56. Depner T, Daugirdas J, Greene T, Allon M, Beck G, Chumlea C, Delmez J, Gotch F, Kusek J, Levin N, Macon E, Milford E, Owen W, Star R, Toto R, Eknoyan G, Hemodialysis Study Group. Dialysis dose and the effect of gender and body size on outcome in the HEMO Study. Kidney Int 2004; 65:1386-1394.
57. Pisoni RL, Bragg-Gresham JL, Young EW, Akizawa T, Asano Y, Locatelli F, Bommer J, Cruz JM, Kerr PG, Mendelssohn DC, Held PJ, Port FK. Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004; 44:94-111.
58. National Kidney Foundation. IV. NKF-K/DOQI clinical practice guidelines for anemia of chronic kidney disease: update 2000. Am J Kidney Dis 2001; 37(1 suppl 1):S182-S238.
59. Lacson E Jr, Ofsthun N, Lazarus JM. Effect of variability in anemia management on hemoglobin outcomes in ESRD. Am J Kidney Dis 2003; 41:111-124.
60. Bommer J, Locatelli F, Satayathum S, Keen ML, Goodkin DA, Saito A, Akiba T, Port FK, Young EW. Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004; 44:661-671.
61. National Kidney Foundation. Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation. Am J Kidney Dis 2000; 35(6 suppl 2):S1-S140.
62. Fissell RB, Bragg-Gresham JL, Gillespie BW, Goodkin DA, Bommer J, Saito A, Akiba T, Port FK, Young EW. International variation in vitamin prescription and association with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004; 44:293-299.
63. http//www.who.int/research/en/
64. Wong JS, Port FK, Hulbert-Shearon TE, Carroll CE, Wolfe RA, Agodoa LY, Daugirdas JT. Survival advantage in Asian American end-stage renal disease patients. Kidney Int 1999; 55:2515-2523.
65. Pei YP, Greenwood CM, Chery AL, Wu GG. Racial differences in survival of patients on dialysis. Kidney Int 2000; 58:1293-1299.
66. Saxena S, Jayaraj PM, Mittal R. Clinical and laboratory features of patients with chronic renal failure at the start of dialysis in North India. Indian J Nephrol 1995; 5:4-8.
67. Abraham G, Varsha P, Mathew M, Sairam VK, Gupta A. Malnutrition and nutritional therapy of chronic kidney disease in developing countries: the Asian perspective. Adv Ren Replace Ther 2003; 10:213-221.
68. Pecoits-Filho R, Lindholm B, Stenvinkel P. The malnutrition, inflammation, and atherosclerosis (MIA) syndrome-the heart of the matter. Nephrol Dial Transplant 2002; 17(suppl 11):28-31.
69. Li PK, Chow KM. The cost barrier to peritoneal dialysis in the developing world-an Asian perspective. Perit Dial Int 2001; 21(suppl 3):S307-S313.
70. Eknoyan G, Lameire N, Barsoum R, Eckardt K, Levin A, Levin N, Locatelli F, Macleod A, Vanholder R, Walker R, Wang H. The burden of kidney disease:improving global outcomes. Kidney Int 2004; 66:1310-1314.